We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
-6.87%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
AUM
$476M
AUM Growth
-$79.9M
Cap. Flow
+$34.6M
Cap. Flow %
7.28%
Top 10 Hldgs %
60.48%
Holding
60
New
14
Increased
9
Reduced
11
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 38.27%
2 Healthcare 24.13%
3 Industrials 2.58%
4 Consumer Staples 0.43%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RFIL icon
26
RF Industries
RFIL
$142M
$4.04M 0.85%
495,037
WTT
27
DELISTED
Wireless Telecom Group, Inc.
WTT
$3.87M 0.81%
1,867,639
+787,291
+73% +$2M
RNAZ icon
28
TransCode Therapeutics
RNAZ
$4.52M
$3.8M 0.8%
+2
New +$4.62M
BKTI icon
29
BK Technologies
BKTI
$292M
$3.79M 0.8%
268,000
ALNA
30
DELISTED
Allena Pharmaceuticals
ALNA
$3.61M 0.76%
4,000,000
BWAY
31
Brainsway
BWAY
$628M
$3.55M 0.75%
880,602
-639,398
-42% -$2.71M
HTGM
32
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$3.49M 0.73%
51,000
PCSA icon
33
Processa Pharmaceuticals
PCSA
$6.37M
$3.32M 0.7%
774
ASYS icon
34
Amtech Systems
ASYS
$261M
$3.12M 0.66%
+273,100
New +$2.8M
DAIO icon
35
Data I/O
DAIO
$30.7M
$2.73M 0.57%
418,310
MDNA
36
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$2.54M 0.54%
915,000
ACTG icon
37
Acacia Research
ACTG
$451M
$2.46M 0.52%
+362,906
New +$2.22M
CYTH
38
CALL
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$2.36M 0.5%
+350,000
New +$2.74M
EVOK
39
DELISTED
Evoke Pharma
EVOK
$2.21M 0.47%
11,814
IPWR icon
40
Ideal Power
IPWR
$70.1M
$2.2M 0.46%
144,347
ALIM
41
DELISTED
Alimera Sciences
ALIM
$2.12M 0.44%
501,025
ANVS icon
42
Annovis Bio
ANVS
$79.1M
$2.11M 0.44%
66,469
-60,000
-47% -$3.45M
NLSPW
43
CALL
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$2.07M 0.44%
827,921
YTEN
44
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$2.05M 0.43%
14,250
ONDS icon
45
Ondas Inc
ONDS
$4.98B
$1.9M 0.4%
207,070
-745,797
-78% -$5.66M
SCYX icon
46
SCYNEXIS
SCYX
$51.6M
$1.82M 0.38%
42,891
-141,717
-77% -$7.42M
NUWE icon
47
Nuwellis
NUWE
$594K
0
DRMA icon
48
CALL
Dermata Therapeutics
DRMA
$4.46M
$786K 0.17%
+73
New +$864K
DRMA icon
49
Dermata Therapeutics
DRMA
$4.46M
$786K 0.17%
+73
New +$864K
ARDS
50
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$554K 0.12%
150,591
-308,670
-67% -$1.43M

Similar funds

AIGH Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, AIGH Capital Management held 60 positions worth $476M, down 14% from $555M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

AIGH Capital Management deployed $34.6M of net new capital in Q3 2021, opening 14 new positions and adding to 9 existing holdings. Its largest new stake was Silicon Motion: 1,468,735 shares worth $29.1M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Cyberoptics Corp, an estimated $13.4M trimmed.

  • AIGH Capital Management's largest Q3 2021 buy was Silicon Motion: 1,468,735 shares worth $29.1M.
  • AIGH Capital Management added most to 02Micro International in Q3 2021, an estimated $4.23M increase.
  • AIGH Capital Management's biggest Q3 2021 reduction was Cyberoptics Corp, cutting an estimated $13.4M.
  • AIGH Capital Management fully exited Aspen Aerogels in Q3 2021, selling an estimated $19.6M.
  • AIGH Capital Management's ten largest holdings make up 60% of its $476M portfolio in Q3 2021.
  • AIGH Capital Management opened 14 new positions and closed 8 in Q3 2021.
  • AIGH Capital Management's portfolio value fell 14% quarter-over-quarter to $476M.

Based on AIGH Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.